Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Mol Cell Endocrinol. 2021 May 24;533:111332. doi: 10.1016/j.mce.2021.111332

TABLE 1.

Characteristics of antibodies used

Target Antibody sequence Name of Antibody Manufacturer, Catalog Number Polyclonal or Monoclonal Dilution Used
Amh (MIS) Genetic locus: AMH (human) mapping to 19 p13.3; AMH (mouse) mapping to 10C1 MIS (C-20) Santa Cruz Biotechnologies, Sc-6886 MW (AMH) 70/74 kDa Mouse monoclonal IgG 1:2000
Dhh Genetic locus: DHH (human) mapping to 12q13.12; Dhh (mouse) mapping to 15F1 Dhh (F9): sc-2711688 Santa Cruz Biotechnologies, sc-2711688 MW (Dhh) 42 kDa Mouse monoclonal IgG 1:1000
Cyp11A1 Recombinant full-length protein corresponding to Human CYP11A1 aa 40–320 mapping to 10q24.32 Anti-Cypl 1A1 antibody Abcam, Ab175408 MW (Cyp11A1) 55 kDa Rabbit polyclonal IgG 1:1000
17ßHSD Genetic locus: HSD17B1 (human) mapping to 17q21.2 17ß-HSD (A5) Santa Cruz Biotechnologies, Sc-376719 MW (17ß-HSD) 35 kDa Mouse monoclonal IgG 1:2000
ACTB Epitope mapping at the C\ terminus of actin of human origin Beta Actin antibody (GT5512) GeneTex, GTX629630 Mouse monoclonal IgG 1:2000

Abbreviations: ACTB= actin; Amh (MIS) = Mullerian inhibiting substance; CPY11A1 = Cytochrome P450 side cleavage enzyme; Dhh= Desert hedgehog; HSD= hydroxysteroid dehydrogenase; MW, molecular weight